-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA: ON JULY 9, FDA APPROVES ISATUXIMAB-IRFC FOR SUBCUTANEOUS INJECTION FOR MULTIPLE MYELOMA INDICATIONS

Reuters·07/10/2026 12:13:28

Please log in to view news